 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction / Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products / Modifiers / Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Enzyme Replacement / Modifying Agents
|
|
Gastrointestinal Agents
|
|
Genitourinary Agents
|
|
Hormonal Agents
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
 Ophthalmic Agents
|
Ophthalmic Anti-allergy Agents
|
Azelastine
|
Bepotastine
|
Cromolyn
|
Emedastine
|
Epinastine
|
Lodoxamide
|
Nedocromil
|
Olopatadine
|
 D08293 Olopatadine (INN)
D01192 Olopatadine hydrochloride (JAN/USAN)
|
Pemirolast
|
Ophthalmic Antiglaucoma Agents
|
Ophthalmic Anti-inflammatories
|
Ophthalmic Prostaglandin and Prostamide Analogs
|
Ophthalmic Agents, Other
|
|
Otic Agents
|
|
Respiratory Tract Agents
|
Antihistamines
|
Histamine1 (H1) Receptor Antagonists, Mildly / Non-sedating
|
Azelastine
|
Cetirizine
|
Desloratadine
|
Fexofenadine
|
Levocetirizine
|
Olopatadine
|
D08293 Olopatadine (INN)
D01192 Olopatadine hydrochloride (JAN/USAN)
|
Histamine1 (H1) Receptor Antagonists, Sedating
|
Anti-inflammatories, Inhaled Corticosteroids
|
Antileukotrienes
|
Bronchodilators, Anticholinergic
|
Bronchodilators, Phosphodiesterase Inhibitors (Xanthines)
|
Bronchodilators, Sympathomimetic
|
Mast Cell Stabilizers
|
Pulmonary Antihypertensives
|
Respiratory Tract Agents, Other
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
|
Therapeutic Nutrients / Minerals / Electrolytes
|
USP Drug Classification